Genetic Studies of Urologic Chronic Pelvic Pain Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostatitis
- Sponsor
- Beth Israel Deaconess Medical Center
- Enrollment
- 300
- Locations
- 1
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
Urologic pelvic pain syndrome (UCPPS), variably termed painful bladder syndrome/interstitial cystitis (PBS/IC) in females and chronic prostatitis/chronic pelvic pain syndrome in men (CP/CPPS), is a chronic, debilitating clinical syndrome presenting as severe pelvic pain with extreme urinary urgency and frequency in the absence of any known cause. The etiologic mechanisms underlying UCPPS are unknown, but recurrence, risks to siblings of affected individuals, concordance among monozygotic twins, and our own preliminary studies indicate a strong genetic contribution to the cause of UCPPS. The overall goal of this proposal is use novel approaches to understand the basis of UCPPS, to identify candidate genes containing mutations that result in UCPPS and determine how the different encoded proteins of these genes interact with one another in a common biological pathway. Ultimately, understanding how mutations in at least five different genes yield the symptoms of UCPPS should lead to improved diagnosis and possible therapies.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Have symptoms for at least 3 months within the preceding 6 months:
- •Pain in the pelvic area
- •Urinary frequency and/or
- •Urinary urgency and/or
- •Sexual dysfunction (erectile dysfunction)
- •Have CP/CPPS, IC, PBS, or BFS
- •Be willing to provide a saliva and urine sample
- •Agree to complete several brief questionnaires
- •Family of someone with CP/CPPS, PBS, IC or BFS
- •Live in the USA or Canada
Exclusion Criteria
- •Major structural/anatomical urinary tract abnormalities
- •Underlying inborn or congenital conditions
Outcomes
Primary Outcomes
Not specified